Borui Pharmaceuticals: The cumulative deviation of the closing price from the reference price in the last 30 trading days has reached 70%.

Borui Pharmaceutical Announcement: The company's stock has deviated by 70% from the closing price for 30 consecutive trading days. According to the relevant regulations of the Shanghai Stock Exchange Trading Rules and the Shanghai Stock Exchange Science and Technology Innovation Board Stock Abnormal Trading Real-time Monitoring Rules, this constitutes a serious abnormal stock trading situation. After conducting a self-inspection, the company's daily operations are currently normal, with no significant changes. There have been no major adjustments in the market environment or industry policies, and there have been no significant fluctuations in production costs and sales. The internal production and operation order is normal.